BSE, Kaynes Tech, M&M, Balrampur Chini, among buzzing stocks as NIFTY, SENSEX gain over 1% in noon deals

Benchmark equity indices NIFTY and SENSEX climbed over 1% on Thursday, driven by buying in banking shares and positive global cues amid optimism surrounding the ongoing US-China summit.

The SENSEX jumped 822 points, or 1.10%, to 75,426, while NIFTY advanced 275 points, or 1.19%, to 23,692 at 12:35 pm.

Among the NIFTY constituents, Adani Enterprises, Cipla, Bharti Airtel, Dr Reddy's, HDFC Bank, Hindalco, Eternal, JSW Steel, NTPC, Sun Pharma and Max Healthcare were the major gainers.

On the other hand, HCL Technologies, Tech Mahindra, Infosys, Tata Consultancy Services, Nestlé India, Hindustan Unilever, Eicher Motors and Tata Consumer Products were top NIFTY losers.

Kaynes Technology

The company reported a 21.5% fall in its consolidated profit after tax to ₹91.2 crore in the fourth quarter FY26, compared to ₹116.2 crore in the March quarter of the fiscal year 2025.

Its revenue from operations advanced 26.2% YoY to ₹1,242.64 crore in the quarter under review, as against ₹984.48 crore a year back.

Mahindra & Mahindra

Shares of the automobile company rose 1.43% to ₹3,156.30 per unit on the NSE after the company's wholly-owned subsidiary Mahindra Overseas Investment Company (Mauritius) Limited (MOICML) sold its remaining stake, reflecting 3.58% of CIE Automotive SA's outstanding shares for approximately EUR 126 million.

"As a result, the holding of MOICML in CIE Automotive S.A. would become Nil and it would cease to be the associate of MOICML," it said in an exchange filing.

Sugar stocks

Earlier the exports were under a restricted category, under which a licence was needed for the outbound shipments. "The export policy of Sugar (Raw Sugar, White Sugar and Refined Sugar)…is amended from 'Restricted' to 'Prohibited' with immediate effect till September 30, 2026, or until further orders, whichever is earlier," the notification by the Directorate General of Foreign Trade (DGFT) said.

This order, however, does not apply to sugar exports to the European Union (EU) and the United States under the CXL and Tariff Rate Quota (TRQ) arrangement, respectively.

BSE

Stock exchange BSE hit its 52-week high level of ₹4,040 per share on the NSE on Thursday. In a month's period, the scrip has gained over 22%.

Last week, BSE had reported a 61% increase in its FY26 January-March quarter earnings to ₹795 crore from ₹494 crore a year before. Its revenue surged 85% year-on-year (YoY) to ₹1,564 crore in the quarter under review.

Alembic Pharma

The stock was trading 1.52% higher at ₹779.50 per unit on the NSE.

This comes after the company received United States Food & Drug Administration (USFDA) tentative approval for Darolutamide Tablets, 300 mg, which is used for the treatment of prostate cancer in combination with docetaxel.

In an separate filing, the firm also announced that it has received Establishment Inspection Report (EIR) from the USFDA for its injectable facility (F-III) located at Karakhadi.